Mach Conferences & Events Share Price

Stock market: Sensex, Nifty witness worst weekly decline in 2.5 years

Despite short-term blip, Sun Pharma remains favourite among investors

After a stellar 2024, debt MFs set for best annual performance in 4 years

NSE imposes new eligibility conditions for SME IPOs day after Sebi nod

Sebi directs MIIs to adopt uniform policy on data sharing for research

Please find enclosed herewith copy of the Press Release titled Mach Conferences reports strong sales growth and positive outlook for H2 FY 25 being released today. The same is also being uploaded on the Companys website at www.machconferences.com.

This is further to our letter dated 12th November 2024 wherein we had given you an advance intimation of the upcoming Analyst or Institutional Investor Meeting in terms of Regulation 30 (6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.The Company had conducted MACHs H1FY25 Earnings Call with Several Investors / Analysts on 15th November 2024 at 4:30 P.M.(IST) onwards with respect to the Unaudited Standalone and Consolidated Financial Results of the Company for the First Half Year ended 30th September 2024 and weblink of the Audio Recording of the said Earnings Call was submitted vide our letter dated 16th November 2024.The Transcript of the aforesaid MACHs H1FY25 Earnings Call with Several Investors / Analysts is enclosed herein and is also available on the Companys website and can be accessed at:https://www.machconferences.com/pdf/investors-relations/disclosures/H1FY25-Earnings-Call-Transcript-Nov15-2024.pdf

We wish to inform you that the Company has conducted the Earnings Conference Call on Friday November 15 2024 for the half year ended September 30 2024.The Audio Recording of the aforesaid call is available on the Companys website and can be accessed through the following link: https://www.machconferences.com/audio/investor-relations/disclosure/H1-FY25-Earnings-Call-Recording.mp3

This is in reference to the covering letter of Statement of Deviation(s) or Variation(s) of Funds (PDF Disclosure) submitted to BSE Limited on November 13 2024.We wish to bring to your kind attention that there is a clerical error in the covering letter of Statement of Deviation(s) or Variation(s) of Fund.In the Paragraph 1 of covering letter the term half - year ended November 12 2024 has been inadvertently mentioned whereas the correct term should have been half- year ended September 30 2024.We kindly request you (BSE Limited) and all stakeholders of the Company to read the term as half - year ended September 30 2024 in place of half - year ended November 12 2024 in the covering letter of Statement of Deviation(s) or Variation(s) of Funds.We sincerely apologize for any confusion this may have caused and assure you that this was purely an administrative oversight.

Pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed herewith Statement of Deviation(s) or Variation(s) in utilization of funds raised through Initial Public Offering (IPO) of the Company for the half - year ended November 12 2024 in the prescribed format.We confirm that there has been no deviation or variation in the utilization of proceeds of the Initial Public Offer (IPO) of the Company as mentioned in the objects clause of the Prospectus dated September 06 2024.The aforesaid statement has been reviewed by the Audit Committee and taken on record by the Board at their respective meetings held on November 12 2024.